Detalhe da pesquisa
1.
PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
Acta Neuropathol
; 147(1): 41, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363426
2.
Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications.
Semin Cell Dev Biol
; 99: 133-150, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31542222
3.
Astrocytes: The Stars in Neurodegeneration?
Biomolecules
; 14(3)2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38540709
4.
FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms.
Mol Neurodegener
; 18(1): 5, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653804
5.
Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices.
J Vis Exp
; (175)2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570099
6.
Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition.
Stem Cell Reports
; 16(9): 2213-2227, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33891869